Published in Health Qual Life Outcomes on February 19, 2016
Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials. Clin Ther (2016) 0.83
Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancer. Oncol Lett (2016) 0.81
Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis. Medicine (Baltimore) (2016) 0.81
Linguistic validation of the Spanish version of the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Support Care Cancer (2016) 0.79
News from the NIH: Person-centered outcomes measurement: NIH-supported measurement systems to evaluate self-assessed health, functional performance, and symptomatic toxicity. Transl Behav Med (2016) 0.75
An investigation of completion times on the Screener and Opioid Assessment for Patients with Pain - revised (SOAPP-R). J Pain Res (2016) 0.75
Assessing the Equivalence of Paper, Mobile Phone, and Tablet Survey Responses at a Community Mental Health Center Using Equivalent Halves of a 'Gold-Standard' Depression Item Bank. JMIR Ment Health (2017) 0.75
Mind the Mode: Differences in Paper vs. Web-based Survey Modes among Women with Cancer. J Pain Symptom Manage (2017) 0.75
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
Sample size and optimal designs for reliability studies. Stat Med (1998) 6.80
Likert scales, levels of measurement and the "laws" of statistics. Adv Health Sci Educ Theory Pract (2010) 5.89
Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health (2008) 3.99
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health (2008) 3.68
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry (2005) 3.03
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol (2015) 2.09
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst (2014) 2.01
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst (2014) 1.72
Reliability of adverse symptom event reporting by clinicians. Qual Life Res (2011) 1.45
Method of administration of PROMIS scales did not significantly impact score level, reliability, or validity. J Clin Epidemiol (2014) 1.34
A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer (2013) 1.21
Comparison of interactive voice response and written self-administered patient surveys for clinical research. Orthopedics (2001) 1.08
Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Transl Behav Med (2011) 1.07
Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technology. J Clin Psychiatry (2007) 1.06
PRO data collection in clinical trials using mixed modes: report of the ISPOR PRO mixed modes good research practices task force. Value Health (2014) 1.03
Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013. Health Qual Life Outcomes (2015) 0.98
Comparison between patient-reported and clinician-observed symptoms in oncology. Cancer Nurs (2013) 0.97
Testing the measurement equivalence of paper and interactive voice response system versions of the EORTC QLQ-C30. Qual Life Res (2013) 0.89
Measurement equivalence of interactive voice response and paper versions of the EQ-5D in a cancer patient sample. Value Health (2011) 0.86
Evaluation of mode equivalence of the MSKCC Bowel Function Instrument, LASA Quality of Life, and Subjective Significance Questionnaire items administered by Web, interactive voice response system (IVRS), and paper. Qual Life Res (2015) 0.79